Polymyxin E(PME) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Polymyxin E(PME) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-74-1 | 1. BSA-Polymyxin E(PME) 2. Anti-Polymyxin E(PME) mouse monoclonal antibody | $2709.00 |
GMP-SMT-74-2 | 1. OVA-Polymyxin E(PME) 2. Anti-Polymyxin E(PME) mouse monoclonal antibody | $2709.00 |
GMP-SMT-74-3 | 1. BSA-Polymyxin E(PME) 2. Anti-Polymyxin E(PME) human monoclonal antibody | $2709.00 |
GMP-SMT-74-4 | 1. OVA-Polymyxin E(PME) 2. Anti-Polymyxin E(PME) human monoclonal antibody | $2709.00 |
GMP-SMT-74-Ag-1 | BSA-Polymyxin E(PME) | $756.00 |
GMP-SMT-74-Ag-2 | OVA-Polymyxin E(PME) | $756.00 |
GMP-SMT-74-Ab-1 | Anti-Polymyxin E(PME) mouse monoclonal antibody | $1953.00 |
GMP-SMT-74-Ab-2 | Anti-Polymyxin E(PME) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Polymyxin E(PME)
Cat No. | GMP-SMT-74-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Polymyxin E(PME) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Polymyxin E(PME) had been validated with our anti-Hapten antibody Anti-Polymyxin E(PME) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Polymyxin E(PME)
Cat No. | GMP-SMT-74-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Polymyxin E(PME) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Polymyxin E(PME) had been validated with our anti-Hapten antibody Anti-Polymyxin E(PME) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Polymyxin E(PME) mouse monoclonal antibody
Cat No. | GMP-SMT-74-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.50 |
Products description | The anti-Hapten antibody against hapten Polymyxin E(PME) had been validated with our hapten hapten-carrier conjugates BSA-Polymyxin E(PME) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Polymyxin E(PME) human monoclonal antibody
Cat No. | GMP-SMT-74-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.50 |
Products description | The anti-Hapten antibody against hapten Polymyxin E(PME) had been validated with our hapten hapten-carrier conjugates BSA-Polymyxin E(PME) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
Basic Orange (BO/CSD) is a type of basic dye and belongs to the xanthene family. It is widely used in various industrial sectors, including textiles, paper manufacturing, and plastic production, as a coloring agent. BO/CSD's chemical structure consists of a pyridine ring and an amino group (-NH2), with variations in the substituents attached to the pyridine ring affecting its properties and applications.
BO/CSD's usage has raised concerns about its potential risks to the environment and human health. The dye can enter the environment through wastewater discharges, leaching from landfills, or accidental spills, leading to water and soil contamination. BO/CSD's environmental persistence and resistance to degradation have raised concerns about its long-term effects on ecosystems.
Studies suggest that BO/CSD can have toxic effects on aquatic organisms, such as fish and algae. When exposed to BO/CSD, these organisms can experience changes in their behavior, growth, and reproductive capabilities. Moreover, BO/CSD's presence in surface water can disrupt the food chain and cause a cascade of adverse impacts on the aquatic ecosystem.
Additionally, BO/CSD's release into the environment can pose a risk to human health. According to some researchers, prolonged exposure to BO/CSD can lead to skin irritation, respiratory problems, and other health issues. Furthermore, the breakdown products of BO/CSD in the environment can be more toxic than the original dye, causing additional health risks.
Thus, monitoring the levels of BO/CSD in the environment is critical for assessing potential risks to human health and ecosystems. Regular monitoring of BO/CSD levels in surface water, sediment, and biota helps to identify pollution sources and implement measures to minimize its inputs into the environment. Analyzing BO/CSD concentrations aids in identifying pollution sources, developing pollution control strategies, and promoting sustainable practices.
Various analytical techniques are available for detecting and quantifying BO/CSD concentrations in environmental samples, including fluorescence spectroscopy, spectrophotometry, and high-performance liquid chromatography (HPLC). These methods provide accurate and precise measurements of BO/CSD levels in environmental matrices, enabling the evaluation of the potential risks associated with BO/CSD contamination.
In conclusion, Basic Orange (BO/CSD) is an extensively used industrial dye that raises concerns about its potential impact on human health and the environment. Ongoing monitoring of BO/CSD levels in environmental samples is crucial for identifying pollution sources and developing effective management strategies to minimize potential risks. Analytical techniques play a vital role in quantifying BO/CSD concentrations and providing critical information to regulatory agencies to safeguard public health and preserve the integrity of ecosystems. Implementing sustainable practices and utilizing safer alternatives can reduce the potential risks associated with BO/CSD and other hazardous dyes.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.